Upgrading Novopen insulin injection systems - 25 years experience

QR Code

Upgrading Novopen insulin injection systems - 25 years experience

The article deals with the estimate of efficiency and safety evaluation of Novopen insulin injection systems

Enregistré dans:

Détails bibliographiques
Auteur principal:	Gagik Radikovich Galstyan
Format:	article
Langue:	EN RU
Publié:	Endocrinology Research Centre 2011
Sujets:	injection systems insulin therapy efficiency safety Nutritional diseases. Deficiency diseases RC620-627
Accès en ligne:	https://doaj.org/article/5fb93be2f62c410c8e35e39fdca2ecf3
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

National advisory board on diabetes mellitus: unsolved issues and new opportunities for diabetes treatment
par: Gagik Radikovich Galstyan
Publié: (2014)

Possible applications of gliptins (dipeptidyl peptidase-4 inhibitors) in patients with type 2 diabetes mellitus on the various modes of insulin therapy
par: Gagik Radikovich Galstyan, et autres
Publié: (2015)

Risk of oncological diseases in patients with diabetes mellitus
par: Gagik Radikovich Galstyan
Publié: (2009)

Fiziologicheskaya rol' inkretinov:perspektivy lecheniya bol'nykhsakharnym diabetom 2 tipa
par: Gagik Radikovich Galstyan
Publié: (2006)

Vliyanie amilina na funktsiyu beta-kletok i regulyatsiyu uglevodnogo obmena
par: Gagik Radikovich Galstyan
Publié: (2008)

International guidelines on the study of glycated hemoglobin HbA1c level as a diagnostic criterion for diabetes mellitus and otherdisorders of carbohydrate metabolism
par: Gagik Radikovich Galstyan
Publié: (2010)

EDGE study in Russian Federation: efficacy and safety of vildagliptine in comparison with other oral antidiabetic agents in patients with type 2 diabetes mellitus
par: Gagik Radikovich Galstyan
Publié: (2013)

69th Scientific Session of American Diabetes Association (ADA), 5-9 June 2009, New Orlean
par: Gagik Radikovich Galstyan
Publié: (2009)

Klinicheskie aspekty ispol'zovaniya pervogo analoga chelovecheskogo GPP-1 dlitel'nogo deystviya ? liraglutida pri SD 2 tipa
par: Gagik Radikovich Galstyan
Publié: (2009)

2-y Mezhdunarodnyy simpozium ?Diabeticheskaya stopa: khirurgiya, terapiya, reabilitatsiya?
par: K Yu Pryakhina, et autres
Publié: (2008)

Diabeticheskaya makroangiopatiya nizhnikh konechnostey: klinika, diagnostika, taktika lecheniya
par: Gagik Radikovich Galstyan, et autres
Publié: (2001)

Lipodystrophy at the insulin injection sites: current trends in epidemiology, diagnostics and prevention
par: Vadim V. Klimontov, et autres
Publié: (2020)

Osteoporosis and diabetes mellitus: a modern viewpoint
par: Natalya Alexandrovna Molitvoslovova, et autres
Publié: (2013)

Principles of care in diabetic foot patients in Russia
par: Gagik Radikovich Galstyan, et autres
Publié: (2009)

The injection technique: results of a questionnaire study of diabetic patients in Russia. New international guidelines on the injectiontechnique
par: Olga Georgievna Mel'nikova, et autres
Publié: (2010)

Role of distal diabetic polyneuropathy in the development of media calcification in patients with diabetesmellitus
par: Natalya Alexandrovna Molitvoslovova, et autres
Publié: (2012)

Novosti s kongressa Amerikanskoy diabeticheskoy assotsiatsii
par: Gagik Radikovish Galstyan
Publié: (2008)

Algoritmy vybora perevyazochnogo materialadlya lecheniya sindroma diabeticheskoy stopy (na primere povyazok firmy Paul Hartmann)
par: Oleg Viktorovich Udovichenko, et autres
Publié: (2006)

Sovremennye printsipy vedeniya bol'nykh s sindromom diabeticheskoy stopy
par: Gagik Radikovich Galstyan, et autres
Publié: (2005)

On the safety of insulin Glargine
par: Ivan Ivanovich Dedov, et autres
Publié: (2009)

The use of the VersaJet hydrosurgical system in patients with diabetic foot syndrome
par: Lyudmila Petrovna Doronina, et autres
Publié: (2010)

Alpha-lipoic acid in non-proliferative diabetic retinopathy treatment by Demydova T.Yu., Trachtenberg Yu.A.: article critique
par: Dmitriy Valentinovich Lipatov, et autres
Publié: (2011)

Sistema osteoprotegerin (OPG) -ligand retseptora-aktivatora yadernogo faktora kappa-V (RANKL) pri diabeticheskoy neyroosteoartropatii i obliteriruyushchem ateroskleroze arteriy nizhnikh konechnostey
par: Марианна Viktorovna Yaroslavtseva, et autres
Publié: (2007)

Lantus, the first peakless basal insulin analogue: 10 years of clinical experience in children and adolescents
par: Tamara Leonidovna Kuraeva
Publié: (2014)

Lypohypertrophy in patients receiving insulin therapy: state of the art
par: Natalya Ivanovna Volkova, et autres
Publié: (2011)

Sovremennye immobilizatsionnye materialy v lechenii sindroma diabeticheskoy stopy
par: Alla Yur'evna Tokmakova, et autres
Publié: (2001)

Rezistentnost' vozbuditeley ranevoy infektsii pri sindrome diabeticheskoy stopy k antibiotikam
par: Oleg Viktorovich Udovichenko, et autres
Publié: (2007)

Sovremennaya kontseptsiya vedeniya bol'nykh s khronicheskimi ranami i sakharnym diabetom
par: Alla Yur'evna Tokmakova, et autres
Publié: (2005)

Osnovnye printsipy lecheniya diabeticheskoyneyroosteoartropatii
par: Irina Nikolaevna Ul'yanova, et autres
Publié: (2006)

Insulin therapy during pregnancy in women with type 1 diabetes
par: V V Potin, et autres
Publié: (2009)

Insulin pump therapy of type 1 diabetes mellitus in children and adolescents in the Moscow region
par: Elena Efimovna Petryaykina, et autres
Publié: (2009)

Insulin therapy and body weight: benefits of biphasic human insulin analogue NovoMix 30
par: Elena Viktorovna Surkova
Publié: (2013)

The clinical course of critical limb ischaemia and the role of endovascular revascularisation in patients with diabetes
par: Olga Nikolaevna Bondarenko, et autres
Publié: (2015)

Early insulin therapy Coordination Council
par: Marina Vladimirovna Shestakova
Publié: (2012)

Overcoming marked insulin resistance in a patient with type 2 diabetes mellitus by means of insulin pumptherapy
par: Ekaterina Viktorovna Artemova, et autres
Publié: (2012)

Pharmacoeconomic analysis of clinical efficiency of combined metformin (Siofor) - insulin therapy in patients with type 2 diabetes mellitus
par: I Yu Demidova, et autres
Publié: (2009)

Humalog Mix 25 in the treatment of type 2 diabetes mellitus
par: Vladimir Ivanovich Zoloedov, et autres
Publié: (2012)

Consensus statement by a panel of experts of the Russian Association of Endocrinologists (RAE) on initiation and intensificationof hypoglycemic therapy for type 2 diabetes mellitus
par: Ivan Ivanovich Dedov, et autres
Publié: (2011)

When basal insulin is not enough: successful strategies for insulin intensification in patients with type 2 diabetes mellitus
par: Elena V. Buryukova, et autres
Publié: (2017)

Modern basal insulins: an ongoing story or the start of a new era?
par: Ivan Ivanovich Dedov
Publié: (2015)